ROIV · Roivant Sciences Ltd. · Share Buybacks
$35.50
+0.00 (+0.00%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$25.86B
Shares
722.32M
Volume · Oct 2
4.39M
Avg daily vol (3M)
7.01M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$1,500,000,000
as of 2025-06-30
Remaining Authorization
$681,700,000
as of 2026-06-30
Program Utilization
54.6%
$818,300,000 used of $1,500,000,000
Repurchase Programs
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-09-19 | — | $400,000,000 | $400,000,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-06 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 YTD | $208,293,000 | 10-Q, filed 2026-02-06 | ||
| 2025-03-31 | $1,293,232,000 | 10-K, filed 2025-05-29 | ||